Evaluation of MK-1075 in Participants With Hepatitis C Virus (HCV) Infection (MK-1075-002)
Clinical trial NCT02392494 · COMPLETED
Trial details
- NCT number
- NCT02392494
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-28
- Primary completion
- 2015-08-10
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.